Maggiore Christopher D. 4

What Happened Christopher D. Maggiore, listed as a 10% owner of Zivo Bioscience, purchased 1,766 shares of ZIVO on January 14, 2026. The reported price was $8.49 per share, for a total transaction value of roughly $14,993. This was recorded on a Form 4 as a purchase (code P — open market or private purchase), which is generally viewed as a bullish signal compared with sales, though motivations are not disclosed.

Key Details

• Transaction date and price: 2026-01-14 at $8.49 per share.
• Shares acquired: 1,766; total reported value: $14,993.
• Transaction code: P (purchase — open market or private purchase).
• Shares owned after transaction: not specified in the Form 4 provided.
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other special conditions are disclosed in the filing.
• Timeliness: Form was filed on 2026-01-27 for a 2026-01-14 transaction, which appears to be a late filing (Form 4s are generally due within 2 business days).

Context As a 10% owner, Maggiore is a significant shareholder; this is insider ownership reporting rather than a routine executive payroll event. Purchases by insiders can be informative to investors, but they do not by themselves explain the buyer’s reasons; no additional explanatory notes were provided in the filing.